NRx Pharmaceuticals’ Hope Therapeutics to acquire Dura Medical, no terms

Hope Therapeutics, an interventional psychiatry network wholly owned by NRx Pharmaceuticals (NRXP), announced signing of a definitive agreement to acquire Dura Medical per the previously announced non-binding Letter of Intent. Dura, together with the previously announced Neurospa network, are anticipated to provide a comprehensive service offering to patients on Florida’s west coast. Dura is revenue generating and EBITDA positive. The intended closing of the of Dura acquisition is subject to completion of financial audits, regulatory approvals, and the satisfaction of standard closing conditions.